8 June 2023

Anti JAKS Biologics EULAR Rheumatoid Arthritis

JAKis don’t beat TNFis in high-risk patients

1 June 2023

Biologics Medications Osteoporosis Pharmaceuticals Women

Denosumab beats alendronate on fracture risk

25 May 2023

Biologics giant cell arteritis

Secukinumab promise in GCA

27 April 2023

Biologics Lupus

Biologics don’t increase infection risk in lupus

16 March 2023

Biologics Corticosteroids Polymyalgia Rheumatica

Rituximab a one-shot stop for PMR?

9 March 2023

Biologics Corticosteroids FDA Polymyalgia Rheumatica

Finally, modern medicine for PMR

2 March 2023

Biologics Dermatology

Monoclonal antibody hope for hidradenitis suppurativa

1 December 2022

Biologics PBS Political

Australian Prescriber staff facing Xmas layoff

3 November 2022

Biologics COVID-19 Research

Should rheums play the long covid game harder?

21 September 2022

Biologics Reactive Arthritis

Reducing risk of HCQ retinopathy comes at a cost

1 September 2022

Biologics PBS

Let the rituximab flow

1 September 2022

Biologics Spondyloarthritis

Triple therapy: the patients’ perspective

18 August 2022

Biologics

ACR releases new vaccination guidelines

21 July 2022

Biologics Rheumatoid Arthritis

Metformin hope for knee OA

14 July 2022

Biologics COVID-19 PBS

Covid antiviral access expanded

23 June 2022

Biologics Gout PBAC

‘Game-changer’ on horizon for alopecia areata